Related references
Note: Only part of the references are listed.Mechanisms of apoptosis modulation by curcumin: Implications for cancer therapy
Keywan Mortezaee et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Interspecies differences in stability kinetics and plasma esterases involved in hydrolytic activation of curcumin diethyl disuccinate, a prodrug of curcumin
Pahweenvaj Ratnatilaka Na Bhuket et al.
RSC ADVANCES (2019)
A curcumin-diglutaric acid conjugated prodrug with improved water solubility and antinociceptive properties compared to curcumin
Chawanphat Muangnoi et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2018)
Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies
Alessandro Allegra et al.
CANCER INVESTIGATION (2017)
Enhancement of Curcumin Bioavailability Via the Prodrug Approach: Challenges and Prospects
Pahweenvaj Ratnatilaka Na Bhuket et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2017)
Pharmacokinetics of Curcumin Diethyl Disuccinate, a Prodrug of Curcumin, in Wistar Rats
Kunan Bangphumi et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2016)
Simultaneous determination of curcumin diethyl disuccinate and its active metabolite curcumin in rat plasma by LC-MS/MS: Application of esterase inhibitors in the stabilization of an ester-containing prodrug
Pahweenvaj Ratnatilaka Na Bhuket et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)
Curcumin Modulates Macrophage Polarization Through the Inhibition of the Toll-Like Receptor 4 Expression and its Signaling Pathways
Yaoyao Zhou et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Comparison of the effects of curcumin and curcumin glucuronide in human hepatocellular carcinoma HepG2 cells
Motomu Shoji et al.
FOOD CHEMISTRY (2014)
Cellular and molecular mechanisms of hepatocellular carcinoma: an update
Rajagopal N. Aravalli et al.
ARCHIVES OF TOXICOLOGY (2013)
Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): Anti-inflammatory and anti-cancer properties
Anlys Olivera et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
Curcumin induced HepG2 cell apoptosis-associated mitochondrial membrane potential and intracellular free Ca2+ concentration
Mu Wang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Synthesis, Characterization and Biological Evaluation of Succinate Prodrugs of Curcuminoids for Colon Cancer Treatment
Wisut Wichitnithad et al.
MOLECULES (2011)
Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment
Purusotam Basnet et al.
MOLECULES (2011)
Dietary Curcumin Increases Antioxidant Defenses in Lung, Ameliorates Radiation-Induced Pulmonary Fibrosis, and Improves Survival in Mice
James C. Lee et al.
RADIATION RESEARCH (2010)
Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?
Jayaraj Ravindran et al.
AAPS JOURNAL (2009)
Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung
R. E. Harris
INFLAMMOPHARMACOLOGY (2009)
Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells
Simone Reuter et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice
Pornprom Yoysungnoen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells
Larisa Nonn et al.
CARCINOGENESIS (2007)
Induction of apoptosis by curcumin and its implications for cancer therapy
D Karunagaran et al.
CURRENT CANCER DRUG TARGETS (2005)